67Ga scan for evaluating response to therapy in malignant lymphoma

67Ga scintigrams in a patient with malignant lymphoma before and after chemotherapy are presented. 67Ga did not accumulate in the mostly necrotic mass with some viable cells. Negative uptake of 67Ga might reflect necrosis of the tumor; however, it is difficult to detect some residual tumor cells. Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European Journal of Nuclear Medicine 1989, Vol.15 (12), p.800-812
Hauptverfasser: KOIZUMI, K, OGATA, H, UCHIYAMA, G, ARAKI, T, HIHARA, T, MONZAWA, S, KACHI, K, MATSUSAKO, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 812
container_issue 12
container_start_page 800
container_title European Journal of Nuclear Medicine
container_volume 15
creator KOIZUMI, K
OGATA, H
UCHIYAMA, G
ARAKI, T
HIHARA, T
MONZAWA, S
KACHI, K
MATSUSAKO, M
description 67Ga scintigrams in a patient with malignant lymphoma before and after chemotherapy are presented. 67Ga did not accumulate in the mostly necrotic mass with some viable cells. Negative uptake of 67Ga might reflect necrosis of the tumor; however, it is difficult to detect some residual tumor cells. Therefore, negative uptake of 67Ga in the mass seen in X-ray CT may not be totally reliable evidence of eradication of viable tumor cells.
doi_str_mv 10.1007/BF00255500
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00255500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2483139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1189-33f4347c27c33d41683b912907419e369c8bc749176f965f369cad8a4496a753</originalsourceid><addsrcrecordid>eNpFkE1LAzEYhIModa1evAu5eBFW32y-NkdbbBUKXnpf3qZJu7KbXZKt0H9vS4s9Dcw8DMwQ8sjglQHot8kMoJBSAlyRjClmcg2luSYZcAG5MkbfkruUfgBACC5HZFSIkjNuMjJReo40WQzUd5G6X2x2ONRhQ6NLfReSo0NHh62L2O9pHWiLTb0JGAba7Nt-27V4T248Nsk9nHVMlrOP5fQzX3zPv6bvi9wyVpqccy-40LbQlvO1YKrkK8MKA1ow47gytlxZLQzTyhsl_dHBdYlCGIVa8jF5OdXa2KUUna_6WLcY9xWD6nhDdbnhAD-d4H63at36Hz3vPuTP5xwP2xsfMdg6XRqNUsBKyf8AZG1h_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>67Ga scan for evaluating response to therapy in malignant lymphoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>KOIZUMI, K ; OGATA, H ; UCHIYAMA, G ; ARAKI, T ; HIHARA, T ; MONZAWA, S ; KACHI, K ; MATSUSAKO, M</creator><creatorcontrib>KOIZUMI, K ; OGATA, H ; UCHIYAMA, G ; ARAKI, T ; HIHARA, T ; MONZAWA, S ; KACHI, K ; MATSUSAKO, M</creatorcontrib><description>67Ga scintigrams in a patient with malignant lymphoma before and after chemotherapy are presented. 67Ga did not accumulate in the mostly necrotic mass with some viable cells. Negative uptake of 67Ga might reflect necrosis of the tumor; however, it is difficult to detect some residual tumor cells. Therefore, negative uptake of 67Ga in the mass seen in X-ray CT may not be totally reliable evidence of eradication of viable tumor cells.</description><identifier>ISSN: 0340-6997</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/BF00255500</identifier><identifier>PMID: 2483139</identifier><identifier>CODEN: EJNMD9</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject><![CDATA[Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Bleomycin - administration & dosage ; Cyclophosphamide - administration & dosage ; Doxorubicin - administration & dosage ; Gallium Radioisotopes ; Hematologic and hematopoietic diseases ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma - diagnostic imaging ; Lymphoma - drug therapy ; Male ; Medical sciences ; Methotrexate - administration & dosage ; Middle Aged ; Prednisolone - administration & dosage ; Tomography, Emission-Computed, Single-Photon ; Vincristine - administration & dosage]]></subject><ispartof>European Journal of Nuclear Medicine, 1989, Vol.15 (12), p.800-812</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19660185$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2483139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KOIZUMI, K</creatorcontrib><creatorcontrib>OGATA, H</creatorcontrib><creatorcontrib>UCHIYAMA, G</creatorcontrib><creatorcontrib>ARAKI, T</creatorcontrib><creatorcontrib>HIHARA, T</creatorcontrib><creatorcontrib>MONZAWA, S</creatorcontrib><creatorcontrib>KACHI, K</creatorcontrib><creatorcontrib>MATSUSAKO, M</creatorcontrib><title>67Ga scan for evaluating response to therapy in malignant lymphoma</title><title>European Journal of Nuclear Medicine</title><addtitle>Eur J Nucl Med</addtitle><description>67Ga scintigrams in a patient with malignant lymphoma before and after chemotherapy are presented. 67Ga did not accumulate in the mostly necrotic mass with some viable cells. Negative uptake of 67Ga might reflect necrosis of the tumor; however, it is difficult to detect some residual tumor cells. Therefore, negative uptake of 67Ga in the mass seen in X-ray CT may not be totally reliable evidence of eradication of viable tumor cells.</description><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bleomycin - administration &amp; dosage</subject><subject>Cyclophosphamide - administration &amp; dosage</subject><subject>Doxorubicin - administration &amp; dosage</subject><subject>Gallium Radioisotopes</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma - diagnostic imaging</subject><subject>Lymphoma - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methotrexate - administration &amp; dosage</subject><subject>Middle Aged</subject><subject>Prednisolone - administration &amp; dosage</subject><subject>Tomography, Emission-Computed, Single-Photon</subject><subject>Vincristine - administration &amp; dosage</subject><issn>0340-6997</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LAzEYhIModa1evAu5eBFW32y-NkdbbBUKXnpf3qZJu7KbXZKt0H9vS4s9Dcw8DMwQ8sjglQHot8kMoJBSAlyRjClmcg2luSYZcAG5MkbfkruUfgBACC5HZFSIkjNuMjJReo40WQzUd5G6X2x2ONRhQ6NLfReSo0NHh62L2O9pHWiLTb0JGAba7Nt-27V4T248Nsk9nHVMlrOP5fQzX3zPv6bvi9wyVpqccy-40LbQlvO1YKrkK8MKA1ow47gytlxZLQzTyhsl_dHBdYlCGIVa8jF5OdXa2KUUna_6WLcY9xWD6nhDdbnhAD-d4H63at36Hz3vPuTP5xwP2xsfMdg6XRqNUsBKyf8AZG1h_A</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>KOIZUMI, K</creator><creator>OGATA, H</creator><creator>UCHIYAMA, G</creator><creator>ARAKI, T</creator><creator>HIHARA, T</creator><creator>MONZAWA, S</creator><creator>KACHI, K</creator><creator>MATSUSAKO, M</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1989</creationdate><title>67Ga scan for evaluating response to therapy in malignant lymphoma</title><author>KOIZUMI, K ; OGATA, H ; UCHIYAMA, G ; ARAKI, T ; HIHARA, T ; MONZAWA, S ; KACHI, K ; MATSUSAKO, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1189-33f4347c27c33d41683b912907419e369c8bc749176f965f369cad8a4496a753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bleomycin - administration &amp; dosage</topic><topic>Cyclophosphamide - administration &amp; dosage</topic><topic>Doxorubicin - administration &amp; dosage</topic><topic>Gallium Radioisotopes</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma - diagnostic imaging</topic><topic>Lymphoma - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methotrexate - administration &amp; dosage</topic><topic>Middle Aged</topic><topic>Prednisolone - administration &amp; dosage</topic><topic>Tomography, Emission-Computed, Single-Photon</topic><topic>Vincristine - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KOIZUMI, K</creatorcontrib><creatorcontrib>OGATA, H</creatorcontrib><creatorcontrib>UCHIYAMA, G</creatorcontrib><creatorcontrib>ARAKI, T</creatorcontrib><creatorcontrib>HIHARA, T</creatorcontrib><creatorcontrib>MONZAWA, S</creatorcontrib><creatorcontrib>KACHI, K</creatorcontrib><creatorcontrib>MATSUSAKO, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European Journal of Nuclear Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KOIZUMI, K</au><au>OGATA, H</au><au>UCHIYAMA, G</au><au>ARAKI, T</au><au>HIHARA, T</au><au>MONZAWA, S</au><au>KACHI, K</au><au>MATSUSAKO, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>67Ga scan for evaluating response to therapy in malignant lymphoma</atitle><jtitle>European Journal of Nuclear Medicine</jtitle><addtitle>Eur J Nucl Med</addtitle><date>1989</date><risdate>1989</risdate><volume>15</volume><issue>12</issue><spage>800</spage><epage>812</epage><pages>800-812</pages><issn>0340-6997</issn><eissn>1619-7089</eissn><coden>EJNMD9</coden><abstract>67Ga scintigrams in a patient with malignant lymphoma before and after chemotherapy are presented. 67Ga did not accumulate in the mostly necrotic mass with some viable cells. Negative uptake of 67Ga might reflect necrosis of the tumor; however, it is difficult to detect some residual tumor cells. Therefore, negative uptake of 67Ga in the mass seen in X-ray CT may not be totally reliable evidence of eradication of viable tumor cells.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>2483139</pmid><doi>10.1007/BF00255500</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6997
ispartof European Journal of Nuclear Medicine, 1989, Vol.15 (12), p.800-812
issn 0340-6997
1619-7089
language eng
recordid cdi_crossref_primary_10_1007_BF00255500
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Bleomycin - administration & dosage
Cyclophosphamide - administration & dosage
Doxorubicin - administration & dosage
Gallium Radioisotopes
Hematologic and hematopoietic diseases
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma - diagnostic imaging
Lymphoma - drug therapy
Male
Medical sciences
Methotrexate - administration & dosage
Middle Aged
Prednisolone - administration & dosage
Tomography, Emission-Computed, Single-Photon
Vincristine - administration & dosage
title 67Ga scan for evaluating response to therapy in malignant lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T15%3A19%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=67Ga%20scan%20for%20evaluating%20response%20to%20therapy%20in%20malignant%20lymphoma&rft.jtitle=European%20Journal%20of%20Nuclear%20Medicine&rft.au=KOIZUMI,%20K&rft.date=1989&rft.volume=15&rft.issue=12&rft.spage=800&rft.epage=812&rft.pages=800-812&rft.issn=0340-6997&rft.eissn=1619-7089&rft.coden=EJNMD9&rft_id=info:doi/10.1007/BF00255500&rft_dat=%3Cpubmed_cross%3E2483139%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2483139&rfr_iscdi=true